Do you have Parkinson's disease and have trouble with learning, remembering or problem-solving?
What is the purpose of this study?
This study is being conducted to see if safinamide, a research medication, can improve learning, remembering, judging or problem-solving in Parkinson's disease patients experiencing problems in those areas.
Can I participate in this study?
You may be eligible for this study if you meet the following criteria:
Conditions:Parkinson's Disease With Cognitive Impairments
Age: Between 45 - 80 Years
Gender: Male or Female
Detail Study Description
Parkinson’s disease is caused by the progressive impairment of a group of cells in your brain that produce dopamine, an important chemical in your brain that helps regulate movement. Safinamide can help increase the amount of dopamine in the brain, which may improve your Parkinson’s disease symptoms, including cognitive problems that you have been experiencing.
During the study, you will be given Safinimide or a placebo (a lookalike pill without any drugs or medicine). No one involved in your care will know if you are taking the medication or the placebo.